Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-032866

Options or other derivatives

  • Chief Science Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PICKER DONALD H · Chief Science Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-15 Grant or award : show line 1 in the form Stock Options (right to buy) +250,000 789,595 D
Loading xslF345X06/rdgdoc.xml…